GGrantIndex
Sort

130,381 grants matching hiv

Drug Use, Disorder & HIV/AIDS Risk in Juvenile Justice Youth:A Longitudinal Study

$1,132,219
Linda A Teplin · Northwestern University At Chicago · R01 · FY2008 · DA

HUMAN TISSUE AND ORGAN RESOURCE FOR RESEARCH

$1,131,777
John T Lonsdale · National Disease Research Interchange · U42 · FY2007 · RR

Tolerance In Organ Transplantation And Autoimmune Disease By T Cell Immunotoxin

$1,131,747
David M. Neville · National Institute Of Mental Health · Z01 · FY2007 · MH

Using immune complex vaccines to optimize antibody responses to HIV Env

$1,131,742
Catarina E Hioe · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AI

UW Clinical HIV Integrated Research Program

$1,131,684
Ann Cornwall Collier · University Of Washington · U01 · FY2007 · AI

Project 1. Optimization and in vivo evaluation of HIV-1 Env trimer sortase A-conjugated nanoparticles

$1,131,614
Kevin O Saunders · Duke University · U19 · FY2022 · AI

Clinical Trials Network Mid-Atlantic Collaborative Group

$1,131,521
Maxine L Stitzer · Johns Hopkins University · U10 · FY2014 · DA

Neural Immunity in HIV Dementia

$1,131,457
Howard Eliot Gendelman · University Of Nebraska Medical Center · P01 · FY2012 · NS

PS09-991, Kenya: IMPLEMENTATION AND EXPANSION OF HIGH QUALITY HIV PREVENTION, CARE AND TREATMENT

$1,131,456
Dr. Meshack Wanjuki · African Medical And Research Foundation · U2G · FY2015 · PS

Identification of Single Nucleotide Polymorphisms in Cancer-Related Genes

$1,131,249
Michael Dean · Basic Sciences · Z01 · FY2007 · CA

Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA)

$1,131,143
Karen L Cropsey · University Of Alabama At Birmingham · P01 · FY2024 · AA

Community-Based HIV VCT: South Africa

$1,131,062
Thomas J. Coates · University Of California Los Angeles · U01 · FY2010 · MH

Factors Influencing Genetic Transcription Initiation And Termination

$1,130,972
Robert J Crouch · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD

Host-Directed Therapy to Augment anti-M. tuberculosis Responses in the Setting of HIV Co-infection and to Sterilize the Tuberculoma

$1,130,921
Smriti Mehra · Texas Biomedical Research Institute · R01 · FY2023 · AI

HIV/AIDS SURVEILLANCE, HIV INCIDENCE SURVEILLANCE, VARIANT

$1,130,902
Kathleen A Brady · Philadelphia Departmentof Public Health · U62 · FY2009 · PS

AIDS Clinical Trials Group Network

$1,130,883
Constance Ann Benson · Social And Scientific Systems, Inc. · U01 · FY2009 · AI

Dynamics and Genetics of HIV Proviruses before and during Antiretroviral Therapy

$1,130,777
Mary Kearney · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

PS10-10138, EXPANDED HIV TESTING FOR DISPROPORTIONATELY AFFECTED POPULATIONS

$1,130,690
Tonya J. Crook · Pennsylvania State Univ Hershey Med Ctr · U62 · FY2010 · PS

Women and Infants Transmission Study IV - Chicago

$1,130,683
University Of Illinois At Chicago · U01 · FY2003 · AI

Administrative Core

$1,130,660
Yukari C Manabe · Johns Hopkins University · U54 · FY2023 · EB

Effects of genetic polymorphism in MHC, KIR, and related loci on human disease

$1,130,585
Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Core-002

$1,130,492
Richard Thomas Wyatt · Scripps Research Institute, The · P01 · FY2023 · AI

Observational Antiretroviral Studies In Southern Africa (OASIS) Collaboration

$1,130,415
Matthias Egger · Universitat Bern · U01 · FY2006 · AI

Efficacy/Effectiveness of Unhealthy Drug Use Screening/Brief Intervention Models

$1,130,308
Richard Saitz · Boston Medical Center · R01 · FY2011 · DA

Clinical Research in the NIMH Office of the Clinical Director

$1,130,023
Maryland Pao · National Institute Of Mental Health · ZIA · FY2024 · MH